Rapid monitoring of mAb aggregates during the purification process development of therapeutic mAbs using a modified Orbitrap hybrid MS

Posters | 2025 | Thermo Fisher Scientific | ASMSInstrumentation
LC/HRMS, LC/Orbitrap, LC/MS/MS, LC/MS, Software
Industries
Pharma & Biopharma
Manufacturer
Thermo Fisher Scientific
Downloadable PDF for viewing
 

Similar PDF

Aggregates analysis of a bispecific antibody using Orbitrap Excedion Pro BioPharma Hybrid mass spectrometer with extended mass range
Applying UHPLC HRAM MS-MS/MS method to assess host cell protein clearance during the purification process development of therapeutic mAbs
NATIVE MASS SPECTROMETRY DISTINGUISHES HOMO VS HETERO NON-COVALENT DIMERIC AGGREGATES OF MONOCLONAL ANTIBODIES
Agilent Biocolumns - Aggregate/Fragment Analysis - Application Compendium